Whilst the US$46bn offer by Canada’s Valeant Pharmaceuticals International and activist investor William Ackman for Allergan, the US pharmaceuticals group that manufactures Botox, has been described as “compelling” we can…
Valeant, Ackman may have fight on hands for Allergan